Press Releases

Menopause Market is Forecasted to Hit US$ 24.0 Bn By 2031 | CAGR 6.8%

The Global Menopause Market is poised for significant growth, projected to reach a valuation of US$ 24.0 Bn by 2031, driven by a robust compound annua

  • Date: 08 Jun, 2024
  • Author: Sagar Karlekar
Heavy Menstrual Bleeding (HMB) Market is Forecasted to Hit US$ 2.4 Bn By 2031 | CAGR 8.9%

The Global Heavy Menstrual Bleeding (HMB) Market, which falls under the medical devices and pharmaceuticals industries, is expected to reach US$ 2.4 B

  • Date: 16 May, 2024
  • Author: Sagar Karlekar
Fibrocystic Breast Condition Market is Forecasted to Hit US$ 2.2 Bn By 2031 | CAGR 7.8%

The Global Fibrocystic Breast Condition Market, which encompasses the pharmaceutical and medical device industries, is expected to reach US$ 2.2 Bn by

  • Date: 14 May, 2024
  • Author: Sagar Karlekar
Premature Ejaculation Market is Forecasted to Hit US$ 5.8 Bn By 2031 | CAGR 9.2%

Premature Ejaculation Market Expected to Achieve US$ 5.8 Bn by 2031, with registering a CAGR of 9.2% during the forecast year. The global Premature Ej

  • Date: 12 May, 2024
  • Author: Sagar Karlekar
Fallopian Tube Cancer Market is Forecasted to Hit US$ 1,052.1 Mn By 2031 | CAGR 11.2%

Fallopian Tube Cancer Market Expected to Achieve US$ 1,052.1 Million by 2031, registering a CAGR 11.2% during the forecast year. The Fallopi

  • Date: 12 May, 2024
  • Author: Sagar Karlekar
Epithelial Ovarian Cancer Market is Forecasted to Hit US$ 3.9 Bn By 2031 | CAGR 10.2%

The Epithelial Ovarian Cancer Market is Expected to Achieve US$ 3.9 Bn by 2031, registering a CAGR of 10.2% during the forecast period. The Globa

  • Date: 12 May, 2024
  • Author: Sagar Karlekar
Endometriosis Market is Forecasted to Hit US$ 3.8 Bn By 2031 | CAGR 9.8%

The Global Endometriosis Market is expected to reach US$ 3.8 Billion in 2031, registering a CAGR of 9.8% during the forecast period of 2024-2031. The

  • Date: 12 May, 2024
  • Author: Sagar Karlekar
Bacterial Vaginosis Market is Forecasted to Hit US$ 959.7 Mn By 2031 | CAGR 6.8%

The Global Bacterial Vaginosis Market is expected to reach US$ 959.7 Million in 2031, registering a CAGR of 6.8% during the forecast period of 2024-20

  • Date: 12 May, 2024
  • Author: Sagar Karlekar
Anovulation Market is Forecasted to Hit US$ 3.1 Bn By 2031 | CAGR 12.5%

The Global Anovulation Market is expected to reach US$ 3.1 Bn in 2031, with a growth rate of 12.5% from 2024 to 2031. The anovulation market is part o

  • Date: 12 May, 2024
  • Author: Sagar Karlekar
Erectile Dysfunction Market is Forecasted to Hit US$ 6.2 Bn By 2031 | CAGR 8.6%

The Global Erectile Dysfunction Market is expected to reach US$ 6.2 Bn in 2031 with a growth rate of 8.6%. The market encompasses a wide range of phar

  • Date: 08 May, 2024
  • Author: Sagar Karlekar
Charcot-Marie-Tooth Disease Market is Forecasted to Hit US$ 3.1 Bn By 2031 | CAGR 12.5%

The Global Charcot-Marie-Tooth Disease Market is a niche segment within the pharmaceutical industry, focusing on the development and commercialization

  • Date: 08 May, 2024
  • Author: Sagar Karlekar
Cerebrotendinous Xanthomatosis Market is Forecasted to Hit US$ 350.7 Mn By 2031 | CAGR 11.2%

The Global Cerebrotendinous Xanthomatosis Market is expected to reach US$ 350.7 Million by 2031, exhibiting a robust growth rate of 11.2% during the f

  • Date: 07 May, 2024
  • Author: Sagar Karlekar
Autism Spectrum Disorder Market is Forecasted to Hit US$ 15.7 Bn By 2031 | CAGR 12.3%

The Global Autism Spectrum Disorder (ASD) Market is projected to reach US$ 15.7 Bn by 2031, exhibiting a robust compound annual growth rate (CAGR) of

  • Date: 07 May, 2024
  • Author: Sagar Karlekar
Argininosuccinic Aciduria Market is Forecasted to Hit US$ 266.7 Mn By 2031 | CAGR 10.5%

The Argininosuccinic Aciduria Market is a niche segment within the pharmaceuticals industry, focused on developing and providing treatments for a rare

  • Date: 06 May, 2024
  • Author: Sagar Karlekar
Huntington's Disease Treatment Market is Forecasted to Hit US$ 4.4 Bn By 2031 | CAGR 17.8%

The Huntington's Disease Treatment Market is projected to grow at a CAGR of 17.8% from 2024 to 2031 and reach a market size of US$ 4.4 billion by

  • Date: 04 May, 2024
  • Author: Sagar Karlekar